2ML3

Solution Structure of AlgE6R3 subunit from the Azotobacter vinelandii Mannuronan C5-epimerase

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-15N HSQC	0.15 mM [U-13C; U-15N] AlgE6R3-1, 20 mM HEPES-2, 25 mM CaCl2-3, 90 % H20-4, 10 % D20-5	90% H2O/10% D2O		6.9	1 atm	298
2	2D 1H-13C HSQC	0.15 mM [U-13C; U-15N] AlgE6R3-6, 20 mM HEPES-7, 25 mM CaCl2-8, 100 % D20-9	100% D2O		6.9	1 atm	298
3	3D CBCA(CO)NH	0.15 mM [U-13C; U-15N] AlgE6R3-1, 20 mM HEPES-2, 25 mM CaCl2-3, 90 % H20-4, 10 % D20-5	90% H2O/10% D2O		6.9	1 atm	298
4	3D HNCO	0.15 mM [U-13C; U-15N] AlgE6R3-1, 20 mM HEPES-2, 25 mM CaCl2-3, 90 % H20-4, 10 % D20-5	90% H2O/10% D2O		6.9	1 atm	298
5	3D HNCA	0.15 mM [U-13C; U-15N] AlgE6R3-1, 20 mM HEPES-2, 25 mM CaCl2-3, 90 % H20-4, 10 % D20-5	90% H2O/10% D2O		6.9	1 atm	298
6	3D HNCACB	0.15 mM [U-13C; U-15N] AlgE6R3-1, 20 mM HEPES-2, 25 mM CaCl2-3, 90 % H20-4, 10 % D20-5	90% H2O/10% D2O		6.9	1 atm	298
7	3D HBHA(CO)NH	0.15 mM [U-13C; U-15N] AlgE6R3-1, 20 mM HEPES-2, 25 mM CaCl2-3, 90 % H20-4, 10 % D20-5	90% H2O/10% D2O		6.9	1 atm	298
8	3D HN(CO)CA	0.15 mM [U-13C; U-15N] AlgE6R3-1, 20 mM HEPES-2, 25 mM CaCl2-3, 90 % H20-4, 10 % D20-5	90% H2O/10% D2O		6.9	1 atm	298
9	3D HCCH-TOCSY	0.15 mM [U-13C; U-15N] AlgE6R3-1, 20 mM HEPES-2, 25 mM CaCl2-3, 90 % H20-4, 10 % D20-5	90% H2O/10% D2O		6.9	1 atm	298
10	3D HCCH-COSY	0.15 mM [U-13C; U-15N] AlgE6R3-1, 20 mM HEPES-2, 25 mM CaCl2-3, 90 % H20-4, 10 % D20-5	90% H2O/10% D2O		6.9	1 atm	298
11	3D HN(CA)CO	0.15 mM [U-13C; U-15N] AlgE6R3-1, 20 mM HEPES-2, 25 mM CaCl2-3, 90 % H20-4, 10 % D20-5	90% H2O/10% D2O		6.9	1 atm	298
12	3D HNHAHB	0.15 mM [U-13C; U-15N] AlgE6R3-1, 20 mM HEPES-2, 25 mM CaCl2-3, 90 % H20-4, 10 % D20-5	90% H2O/10% D2O		6.9	1 atm	298
13	2D 1H-1H NOESY	0.15 mM [U-13C; U-15N] AlgE6R3-10, 20 mM [U-2H] HEPES-11, 25 mM CaCl2-12, 100 % D20-13	100% D2O		6.9	1 atm	298
14	3D 1H-15N NOESY	0.15 mM [U-13C; U-15N] AlgE6R3-1, 20 mM HEPES-2, 25 mM CaCl2-3, 90 % H20-4, 10 % D20-5	90% H2O/10% D2O		6.9	1 atm	298
15	3D 1H-13C NOESY aliphatic	0.15 mM [U-13C; U-15N] AlgE6R3-6, 20 mM HEPES-7, 25 mM CaCl2-8, 100 % D20-9	100% D2O		6.9	1 atm	298

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE	600

NMR Refinement
Method	Details	Software
simulated annealing		CARA

NMR Ensemble Information
Conformer Selection Criteria	target function
Conformers Calculated Total Number	100
Conformers Submitted Total Number	20
Representative Model	1 (lowest energy)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	chemical shift assignment	CARA		Keller and Wuthrich
2	collection	XwinNMR	3.5	Bruker Biospin
3	processing	XwinNMR	3.5	Bruker Biospin
4	chemical shift assignment	TopSpin	1.3	Krieger E, Koraimann G, Vriend G
5	collection	TopSpin	1.3	Krieger E, Koraimann G, Vriend G
6	refinement	TopSpin	1.3	Krieger E, Koraimann G, Vriend G
7	structure solution	CYANA		Guntert, Mumenthaler and Wuthrich
8	refinement	CYANA		Guntert, Mumenthaler and Wuthrich
9	refinement	YASARA		YASARA Biosciences

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.